Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s11010-022-04483-4.

Title:
Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma | Molecular and Cellular Biochemistry
Description:
Liver cancer is the sixth common cancer and forth cause of cancer-related death worldwide. Based on usually advanced stages of hepatocellular carcinoma (HCC) at the time of diagnosis, therapeutic options are limited and, in many cases, not effective, and typically result in the tumor recurrence with a poor prognosis. Radioimmunotherapy (RIT) offers a selective internal radiation therapy approach using beta or alpha emitting radionuclides conjugated with tumor-specific monoclonal antibodies (mAbs), or specific selective peptides. When compared to chemotherapy or radiotherapy, radiolabeled mAbs against cancer-associated antigens could provide a high therapeutic and exclusive radiation dose for cancerous cells while decreasing the exposure-induced side effects to healthy tissues. The recent advances in cancer immunotherapy, such as blockade of immune-checkpoint inhibitors (ICIs), has changed the landscape of cancer therapy, and the efficacy of different classes of immunotherapy has been tested in many clinical trials. Taking into account the use of ICIs in the liver tumor microenvironment, combined therapies with different approaches may enhance the outcome in the future clinical studies. With the development of novel immunotherapy treatment options in the recent years, there has been a great deal of information about combining the diverse treatment modalities to boost the effectiveness of immunomodulatory drugs. In this opinion review, we will discuss the recent advancements in RIT. The current status of immunotherapy and internal radiotherapy will be updated, and we will propose novel approaches for the combination of both techniques. Graphical abstract Potential target antigens for radioimmunotherapy in Hepatocellular carcinoma (HCC). HCC radioimmunotherapy target antigens are the most specific and commonly accessible antigens on the surface of HCC cells. CTLA-4 ligand and receptor, TAMs, PD-1/PD-L, TIM-3, specific IEXs/TEXs, ROBO1, and cluster of differentiation antigens CD105, CD147 could all be used in HCC radioimmunotherapy. Abbreviations: TAMs, tumor-associated macrophages; CTLA-4, cytotoxic T-lymphocyte associated antigen-4; PD-1, Programmed cell death protein 1; PD-L, programmed death-ligand1; TIM-3, T-cell immunoglobulin (Ig) and mucin-domain containing protein-3; IEXs, immune cell-derived exosomes; TEXs, tumor-derived exosomes.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,643,328 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

article, google, scholar, hepatocellular, carcinoma, cas, cancer, cells, wang, patients, zhang, cell, immunotherapy, oncol, liu, exosomes, liver, tumor, therapy, phase, advanced, immune, yang, res, treatment, trial, chen, radioimmunotherapy, hcc, clin, hepatol, study, antibody, jiang, sorafenib, research, antigens, targeted, mol, lancet, huang, immunol, blockade, future, current, int, biol, checkpoint, clinical, combination,

Topics {✒️}

fak-pi3k-akt-girdin signaling pathway release exosomal mir-23a-3p nf-κb/il-6/stat3 axis anti-pd-l1 antibody mpdl3280a tgf-β/smad signaling pathway 131i-anti-endoglin monoclonal antibody mir-199a-modified exosomes p53-dependent signaling pathway massoud vosough anti-vegf/vegfr therapy month download article/chapter pfkfb3-pd-l1 axis immune cell-derived exosomes increased α-fetoprotein concentrations pd-l1 significantly associates hbv-related hepatocellular carcinoma exosomal pd-l1 contributes small-cell lung cancer nonconventional antigen-presenting cells intra-tumoral expression levels pd-1 antibody increase immune-checkpoint inhibitors immune checkpoint inhibitors tumor-related exosomes contribute cancer-related death worldwide targeted alpha therapy hepatocellular carcinoma-derived exosomes advanced/metastatic hepatocellular carcinoma anti-cancer target targeted cancer therapy exposure-induced side effects molecular research center essential exosome components tgf-β signaling anti-angiogenic therapy anti-endoglin antibody immune checkpoint blockade epithelial–mesenchymal-transition epithelial-mesenchymal transition robo1-targeted radioimmunotherapy commonly accessible antigens exosome mir-335 cytotoxic t-lymphocyte tumor-specific monoclonal antibodies el-khoueiry ab regulatory immune cells dendritic cells pulsed anti-pd-1 response small molecule-based approaches differentiation antigens cd105

Questions {❓}

  • Elsharkasy OM, Nordin JZ, Hagey DW, de Jong OG, Schiffelers RM, Andaloussi SE et al (2020) Extracellular vesicles as drug delivery systems: why and how?
  • Lee HW, Cho KJ, Park JY (2020) Current status and future direction of immunotherapy in hepatocellular carcinoma: what do the data suggest?
  • Mehlen P, Delloye-Bourgeois C, Chédotal A (2011) Novel roles for Slits and netrins: axon guidance cues as anticancer targets?
  • Sahlin M, Bauden MP, Andersson R, Ansari DJTB (2015) Radioimmunotherapy—a potential novel tool for pancreatic cancer therapy?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma
         description:Liver cancer is the sixth common cancer and forth cause of cancer-related death worldwide. Based on usually advanced stages of hepatocellular carcinoma (HCC) at the time of diagnosis, therapeutic options are limited and, in many cases, not effective, and typically result in the tumor recurrence with a poor prognosis. Radioimmunotherapy (RIT) offers a selective internal radiation therapy approach using beta or alpha emitting radionuclides conjugated with tumor-specific monoclonal antibodies (mAbs), or specific selective peptides. When compared to chemotherapy or radiotherapy, radiolabeled mAbs against cancer-associated antigens could provide a high therapeutic and exclusive radiation dose for cancerous cells while decreasing the exposure-induced side effects to healthy tissues. The recent advances in cancer immunotherapy, such as blockade of immune-checkpoint inhibitors (ICIs), has changed the landscape of cancer therapy, and the efficacy of different classes of immunotherapy has been tested in many clinical trials. Taking into account the use of ICIs in the liver tumor microenvironment, combined therapies with different approaches may enhance the outcome in the future clinical studies. With the development of novel immunotherapy treatment options in the recent years, there has been a great deal of information about combining the diverse treatment modalities to boost the effectiveness of immunomodulatory drugs. In this opinion review, we will discuss the recent advancements in RIT. The current status of immunotherapy and internal radiotherapy will be updated, and we will propose novel approaches for the combination of both techniques. Potential target antigens for radioimmunotherapy in Hepatocellular carcinoma (HCC). HCC radioimmunotherapy target antigens are the most specific and commonly accessible antigens on the surface of HCC cells. CTLA-4 ligand and receptor, TAMs, PD-1/PD-L, TIM-3, specific IEXs/TEXs, ROBO1, and cluster of differentiation antigens CD105, CD147 could all be used in HCC radioimmunotherapy. Abbreviations: TAMs, tumor-associated macrophages; CTLA-4, cytotoxic T-lymphocyte associated antigen-4; PD-1, Programmed cell death protein 1; PD-L, programmed death-ligand1; TIM-3, T-cell immunoglobulin (Ig) and mucin-domain containing protein-3; IEXs, immune cell-derived exosomes; TEXs, tumor-derived exosomes.
         datePublished:2022-06-16T00:00:00Z
         dateModified:2022-06-16T00:00:00Z
         pageStart:23
         pageEnd:37
         sameAs:https://doi.org/10.1007/s11010-022-04483-4
         keywords:
            Radioimmunotherapy
            Hepatocellular carcinoma
            Immune checkpoint inhibitor
            Target antigens
            Exosome antigens
            Biochemistry
            general
            Cardiology
            Cancer Research
            Medical Biochemistry
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-022-04483-4/MediaObjects/11010_2022_4483_Figa_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-022-04483-4/MediaObjects/11010_2022_4483_Fig1_HTML.png
         isPartOf:
            name:Molecular and Cellular Biochemistry
            issn:
               1573-4919
               0300-8177
            volumeNumber:478
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Mahsa Pourhamzeh
               affiliation:
                     name:ACECR
                     address:
                        name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
                        type:PostalAddress
                     type:Organization
                     name:UC San Diego
                     address:
                        name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Samieh Asadian
               affiliation:
                     name:ACECR
                     address:
                        name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hamed Mirzaei
               affiliation:
                     name:Kashan University of Medical Sciences
                     address:
                        name:Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Azita Minaei
               affiliation:
                     name:Qazvin University of Medical Sciences
                     address:
                        name:Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Elahe Shahriari
               affiliation:
                     name:UC San Diego
                     address:
                        name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anastasia Shpichka
               affiliation:
                     name:Sechenov First Moscow State Medical University
                     address:
                        name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
                        type:PostalAddress
                     type:Organization
                     name:Sechenov First Moscow State Medical University
                     address:
                        name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
                        type:PostalAddress
                     type:Organization
                     name:Lomonosov Moscow State University
                     address:
                        name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hamidreza Aboulkheyr Es
               affiliation:
                     name:University of Technology Sydney
                     address:
                        name:School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter Timashev
               url:http://orcid.org/0000-0001-7773-2435
               affiliation:
                     name:Sechenov First Moscow State Medical University
                     address:
                        name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
                        type:PostalAddress
                     type:Organization
                     name:Sechenov First Moscow State Medical University
                     address:
                        name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
                        type:PostalAddress
                     type:Organization
                     name:Lomonosov Moscow State University
                     address:
                        name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Moustapha Hassan
               affiliation:
                     name:Karolinska Institute
                     address:
                        name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Massoud Vosough
               affiliation:
                     name:ACECR
                     address:
                        name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
                        type:PostalAddress
                     type:Organization
                     name:Karolinska Institute
                     address:
                        name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma
      description:Liver cancer is the sixth common cancer and forth cause of cancer-related death worldwide. Based on usually advanced stages of hepatocellular carcinoma (HCC) at the time of diagnosis, therapeutic options are limited and, in many cases, not effective, and typically result in the tumor recurrence with a poor prognosis. Radioimmunotherapy (RIT) offers a selective internal radiation therapy approach using beta or alpha emitting radionuclides conjugated with tumor-specific monoclonal antibodies (mAbs), or specific selective peptides. When compared to chemotherapy or radiotherapy, radiolabeled mAbs against cancer-associated antigens could provide a high therapeutic and exclusive radiation dose for cancerous cells while decreasing the exposure-induced side effects to healthy tissues. The recent advances in cancer immunotherapy, such as blockade of immune-checkpoint inhibitors (ICIs), has changed the landscape of cancer therapy, and the efficacy of different classes of immunotherapy has been tested in many clinical trials. Taking into account the use of ICIs in the liver tumor microenvironment, combined therapies with different approaches may enhance the outcome in the future clinical studies. With the development of novel immunotherapy treatment options in the recent years, there has been a great deal of information about combining the diverse treatment modalities to boost the effectiveness of immunomodulatory drugs. In this opinion review, we will discuss the recent advancements in RIT. The current status of immunotherapy and internal radiotherapy will be updated, and we will propose novel approaches for the combination of both techniques. Potential target antigens for radioimmunotherapy in Hepatocellular carcinoma (HCC). HCC radioimmunotherapy target antigens are the most specific and commonly accessible antigens on the surface of HCC cells. CTLA-4 ligand and receptor, TAMs, PD-1/PD-L, TIM-3, specific IEXs/TEXs, ROBO1, and cluster of differentiation antigens CD105, CD147 could all be used in HCC radioimmunotherapy. Abbreviations: TAMs, tumor-associated macrophages; CTLA-4, cytotoxic T-lymphocyte associated antigen-4; PD-1, Programmed cell death protein 1; PD-L, programmed death-ligand1; TIM-3, T-cell immunoglobulin (Ig) and mucin-domain containing protein-3; IEXs, immune cell-derived exosomes; TEXs, tumor-derived exosomes.
      datePublished:2022-06-16T00:00:00Z
      dateModified:2022-06-16T00:00:00Z
      pageStart:23
      pageEnd:37
      sameAs:https://doi.org/10.1007/s11010-022-04483-4
      keywords:
         Radioimmunotherapy
         Hepatocellular carcinoma
         Immune checkpoint inhibitor
         Target antigens
         Exosome antigens
         Biochemistry
         general
         Cardiology
         Cancer Research
         Medical Biochemistry
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-022-04483-4/MediaObjects/11010_2022_4483_Figa_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11010-022-04483-4/MediaObjects/11010_2022_4483_Fig1_HTML.png
      isPartOf:
         name:Molecular and Cellular Biochemistry
         issn:
            1573-4919
            0300-8177
         volumeNumber:478
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Mahsa Pourhamzeh
            affiliation:
                  name:ACECR
                  address:
                     name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
                     type:PostalAddress
                  type:Organization
                  name:UC San Diego
                  address:
                     name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Samieh Asadian
            affiliation:
                  name:ACECR
                  address:
                     name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hamed Mirzaei
            affiliation:
                  name:Kashan University of Medical Sciences
                  address:
                     name:Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Azita Minaei
            affiliation:
                  name:Qazvin University of Medical Sciences
                  address:
                     name:Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Elahe Shahriari
            affiliation:
                  name:UC San Diego
                  address:
                     name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anastasia Shpichka
            affiliation:
                  name:Sechenov First Moscow State Medical University
                  address:
                     name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
                     type:PostalAddress
                  type:Organization
                  name:Sechenov First Moscow State Medical University
                  address:
                     name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
                     type:PostalAddress
                  type:Organization
                  name:Lomonosov Moscow State University
                  address:
                     name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hamidreza Aboulkheyr Es
            affiliation:
                  name:University of Technology Sydney
                  address:
                     name:School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter Timashev
            url:http://orcid.org/0000-0001-7773-2435
            affiliation:
                  name:Sechenov First Moscow State Medical University
                  address:
                     name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
                     type:PostalAddress
                  type:Organization
                  name:Sechenov First Moscow State Medical University
                  address:
                     name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
                     type:PostalAddress
                  type:Organization
                  name:Lomonosov Moscow State University
                  address:
                     name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Moustapha Hassan
            affiliation:
                  name:Karolinska Institute
                  address:
                     name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Massoud Vosough
            affiliation:
                  name:ACECR
                  address:
                     name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
                     type:PostalAddress
                  type:Organization
                  name:Karolinska Institute
                  address:
                     name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Molecular and Cellular Biochemistry
      issn:
         1573-4919
         0300-8177
      volumeNumber:478
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:ACECR
      address:
         name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
         type:PostalAddress
      name:UC San Diego
      address:
         name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
         type:PostalAddress
      name:ACECR
      address:
         name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
         type:PostalAddress
      name:Kashan University of Medical Sciences
      address:
         name:Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
         type:PostalAddress
      name:Qazvin University of Medical Sciences
      address:
         name:Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
         type:PostalAddress
      name:UC San Diego
      address:
         name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
         type:PostalAddress
      name:Sechenov First Moscow State Medical University
      address:
         name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
         type:PostalAddress
      name:Sechenov First Moscow State Medical University
      address:
         name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
         type:PostalAddress
      name:Lomonosov Moscow State University
      address:
         name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
         type:PostalAddress
      name:University of Technology Sydney
      address:
         name:School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia
         type:PostalAddress
      name:Sechenov First Moscow State Medical University
      address:
         name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
         type:PostalAddress
      name:Sechenov First Moscow State Medical University
      address:
         name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
         type:PostalAddress
      name:Lomonosov Moscow State University
      address:
         name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
         type:PostalAddress
      name:Karolinska Institute
      address:
         name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
         type:PostalAddress
      name:ACECR
      address:
         name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
         type:PostalAddress
      name:Karolinska Institute
      address:
         name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Mahsa Pourhamzeh
      affiliation:
            name:ACECR
            address:
               name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
               type:PostalAddress
            type:Organization
            name:UC San Diego
            address:
               name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
               type:PostalAddress
            type:Organization
      name:Samieh Asadian
      affiliation:
            name:ACECR
            address:
               name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
               type:PostalAddress
            type:Organization
      name:Hamed Mirzaei
      affiliation:
            name:Kashan University of Medical Sciences
            address:
               name:Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
               type:PostalAddress
            type:Organization
      name:Azita Minaei
      affiliation:
            name:Qazvin University of Medical Sciences
            address:
               name:Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
               type:PostalAddress
            type:Organization
      name:Elahe Shahriari
      affiliation:
            name:UC San Diego
            address:
               name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
               type:PostalAddress
            type:Organization
      name:Anastasia Shpichka
      affiliation:
            name:Sechenov First Moscow State Medical University
            address:
               name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
               type:PostalAddress
            type:Organization
            name:Sechenov First Moscow State Medical University
            address:
               name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
               type:PostalAddress
            type:Organization
            name:Lomonosov Moscow State University
            address:
               name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
               type:PostalAddress
            type:Organization
      name:Hamidreza Aboulkheyr Es
      affiliation:
            name:University of Technology Sydney
            address:
               name:School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia
               type:PostalAddress
            type:Organization
      name:Peter Timashev
      url:http://orcid.org/0000-0001-7773-2435
      affiliation:
            name:Sechenov First Moscow State Medical University
            address:
               name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
               type:PostalAddress
            type:Organization
            name:Sechenov First Moscow State Medical University
            address:
               name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
               type:PostalAddress
            type:Organization
            name:Lomonosov Moscow State University
            address:
               name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Moustapha Hassan
      affiliation:
            name:Karolinska Institute
            address:
               name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      name:Massoud Vosough
      affiliation:
            name:ACECR
            address:
               name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
               type:PostalAddress
            type:Organization
            name:Karolinska Institute
            address:
               name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
      name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
      name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
      name:Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
      name:Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
      name:Departments of Pathology and Medicine, UC San Diego, La Jolla, USA
      name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
      name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
      name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
      name:School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia
      name:World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov First Moscow State Medical University, Moscow, Russia
      name:Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
      name:Chemistry Department, Lomonosov Moscow State University, Moscow, Russia
      name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
      name:Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
      name:Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(296)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.87s.